2018
MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma
MYTSYK, Yulian, Victor DOSENKO, Yuriy BORYS, Askold KUCHER, Katarina GAZDIKOVA et. al.Základní údaje
Originální název
MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma
Autoři
MYTSYK, Yulian (804 Ukrajina), Victor DOSENKO (804 Ukrajina), Yuriy BORYS (804 Ukrajina), Askold KUCHER (804 Ukrajina), Katarina GAZDIKOVA (703 Slovensko), Dietrich BUSSELBERG (634 Katar), Martin CAPRNDA (703 Slovensko), Peter KRUŽLIAK (703 Slovensko, garant, domácí), Ammad Ahmad FAROOQI (586 Pákistán) a Manyuk LUBOV (804 Ukrajina)
Vydání
International Urology and Nephrology, Dordrecht, Springer, 2018, 0301-1623
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30217 Urology and nephrology
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.596
Kód RIV
RIV/00216224:14110/18:00102916
Organizační jednotka
Lékařská fakulta
UT WoS
000431429000008
Klíčová slova anglicky
Renal cell carcinoma; MiRNA-15a; Biomarker; Diagnosis; Molecular marker
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 16:07, Soňa Böhmová
Anotace
V originále
Currently, there is no accurate diagnostic molecular biomarker for renal cell carcinoma (RCC). The aim of this study was to assess the expression of microRNA-15a (miR-15a) in urine of patients with RCC and to evaluate its potential as a diagnostic molecular biomarker. In total, 67 patients with solid renal tumors were enrolled: clear-cell RCC (ccRCC, n = 22), papillary RCC (pRCC, n = 16), chromophobe RCC (chRCC, n = 14), oncocytoma (n = 8), papillary adenoma (n = 2) and angiomyolipoma (n = 5). MiRNA-15a expression levels measurement in urine were performed using qPCR. Urine of 15 healthy volunteers without kidney pathology was used as control. We observed a difference in mean miR-15a expression values in groups of pre-operative patients with RCC, benign renal tumors and healthy persons (2.50E-01 +/- 2.72E-01 vs 1.32E-03 +/- 3.90E-03 vs 3.36E-07 +/- 1.04E-07 RFU, respectively, p < 0.01). There was no difference in miR-15a expression between ccRCC, pRCC and chRCC (p > 0.05). Direct association between RCC size and miR-15a expression values was obtained (Pearson correlation coefficient-0.873). On the 8th day after nephrectomy, mean expression value in patients with RCC decreased by 99.53% (p < 0.01). MiR-15a expression differentiated RCC from benign renal tumors with 98.1% specificity, 100% sensitivity at a cut-off value of 5.00E-06 RFU, with AUC-0.955. MiR-15a expression measured in urine may be used as diagnostic molecular biomarker for RCC.